Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Immunological Methods|June 3, 2018
A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysisAdam M Swartz, Elizabeth Reap, Pamela Norberg, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 22, 2020
Gating Harmonization Guidelines for Intracellular Cytokine Staining Validated in Second International Multiconsortia Proficiency Panel Conducted by Cancer Immunotherapy Consortium (CIC/CRI)Leah S Price, Matthew Adamow, Sebastian Attig, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 19, 2024
Performance and Stability of New Class of Fetal Bovine Sera (FBS) and Its Lyophilized Form in ELISpot and FluoroSpot Assays: Applications for Monitoring the Immune Response in Vaccine, and Cell and Gene Immunotherapy in Clinical TrialsZhinous Hosseini, Christopher J Groves, Penny Anders, et al.
Cancer Immunology Research|November 13, 2014
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomideDuane A Mitchell, Elias J Sayour, Elizabeth Reap, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2017
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)Sridharan Gururangan, Elizabeth Reap, Robert Schmittling, et al.
Oncoimmunology|December 8, 2018
CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell responseKatherine A Riccione, Li-Zhen He, Peter E Fecci, et al.
IUBMB Life|July 18, 2002
Alphavirus replicon particles as candidate HIV vaccinesNancy L Davis, Ande West, Elizabeth Reap, et al.
Nature Cancer|June 12, 2025
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trialEric M Thompson, David M Ashley, Katayoun Ayasoufi, et al.
Pageof 1